FIELD: chemistry.
SUBSTANCE: invention relates to deuterated derivatives of thienopiperidine with a structure of formula (I) or pharmaceutically acceptable salts thereof
Formula (I),
where X is P or S; m equals 0 or 1; n equals 0 or 1; R1 is selected from hydrogen, linear or branched C1-C4alkyl substituted or unsubstituted with halogen or phenyl; R2 is not substituted or is selected from hydrogen, linear or branched C1-C4alkyl, substituted or unsubstituted with halogen or phenyl, wherein if R2 is not substituted, then X and O form a double bond, as well as a method for production and use thereof for treating and preventing cardiovascular and cerebrovascular diseases.
EFFECT: treatment and prevention of cardiovascular and cerebrovascular diseases.
9 cl, 2 dwg, 4 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
THIENOPYRIDINE ESTER DERIVATIVE, CONTAINING CYANOGROUP, METHOD OF ITS OBTAINING, ITS APPLICATION AND BASED ON IT COMPOSITION | 2011 |
|
RU2526624C2 |
2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
SUBSTITUTED CINNAMAMIDE DERIVATIVE, METHOD FOR PRODUCTION AND USE THEREOF | 2012 |
|
RU2587668C2 |
4-HYDROXYBENZAMIDE DRUG DERIVATIVES | 2007 |
|
RU2465271C2 |
ANTITHROMBOTIC DUAL INHIBITORS CONTAINING BIOTIN LABEL | 2006 |
|
RU2434876C2 |
ROUTES OF APPLICATION OF PHOSPHODIESTERASE INHIBITORS | 2020 |
|
RU2795503C2 |
COMPOUND HAVING THROMBOCYTE AGGREGATION INHIBITION ACTION, AND A SALT THEREOF, AND A COMPOSITION COMPRISING SUCH COMPOUNDS FOR PREVENTING OR TREATING THROMBOTIC DISEASES | 2016 |
|
RU2739915C2 |
PROTEINKINASE INHIBITORS, METHOD FOR OBTAINING THEREOF AND MEDICAL APPLICATION | 2016 |
|
RU2749437C2 |
METHODS OF TREATING OR PREVENTING THROMBOSIS OR EMBOLISM | 2011 |
|
RU2611662C2 |
CRYSTALLINE CLOPIDOGREL NAPHTALENE SULFONATE OR ITS HYDRATE, METHODS FOR ITS PRODUCING AND PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2328501C1 |
Authors
Dates
2020-03-06—Published
2016-06-21—Filed